Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

© 2017, National Academy of Sciences. All rights reserved. Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we devel...

Full description

Bibliographic Details
Main Authors: Ludwig, B., Ludwig, S., Steffen, A., Knauf, Y., Zimerman, B., Heinke, S., Lehmann, S., Schubert, U., Schmid, J., Bleyer, M., Schönmann, U., Colton, C., Bonifacio, E., Solimena, Michele, Reichel, A., Schally, A., Rotem, A., Barkai, U., Grinberg-Rashi, H., Kaup, F., Avni, Y., Jones, P., Bornstein, S.
Format: Journal Article
Published: National Academy of Sciences 2017
Online Access:http://hdl.handle.net/20.500.11937/73057